The Centre plans to bring sterile drug products under a central licensing system following quality concerns involving injectable medicines. About 240 injection samples were found not of standard quality during 2025-26, prompting a proposed shift from State-level licensing to central oversight.
The Telangana Drug Control Administration and TG SAFE have recalled a specific batch of Azima-500 LB tablets after it was declared Not of Standard Quality. Authorities advised the public not to consume the affected batch and directed chemists to withdraw stocks.
Telangana Drug Control Administration has issued an advisory to stop using cough syrups Relife and Respifresh TR, detected with toxic Diethylene Glycol (DEG). Authorities urge reporting possession, alert retailers, and freeze stocks to prevent risks to public health.
Telangana’s Drug Control Administration (DCA) has warned against the illegal OTC sale of abortion kits, saying unsupervised use of Mifepristone and Misoprostol can cause severe bleeding and life-threatening complications. Pharmacies violating prescription rules face strict action under the Drugs and Cosmetics Act.
The Telangana Drug Control Administration found violations in 193 medical shops during inspections aimed at curbing antibiotic misuse and raising awareness on Antimicrobial Resistance. Show cause notices were issued for selling antibiotics without prescriptions and not maintaining regulatory records.
Telangana Drug Control Administration seized fake antidiabetic, antihypertensive, and abortion pills worth Rs. 5.21 lakh from a residence in Malakpet. The seized medicines were falsely labeled as being manufactured by well-known pharmaceutical firms. One offender was identified.
According to DG, TSDCA, V B Kamalasan Reddy, the label of the product bears a misleading claim stating that it treats irregular menstruation, menopausal syndrome and amenorrhea (menstrual disorders).
